Opinion
2023-1374
05-04-2023
TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., Plaintiffs-Appellees v. NORWICH PHARMACEUTICALS INC., Defendant-Appellant
EDGAR HAUG, Haug Partners LLP, New York, NY, argued for plaintiffs-appellees. Also represented by KAITLIN FARRELL, PORTER F. FLEMING, SHEILA MORTAZAVI, ANDREW SCOTT ROPER. CHAD A. LANDMON, Axinn, Veltrop &Harkrider LLP, Hartford, CT, argued for defendant-appellant. Also represented by THOMAS K. HEDEMANN, EDWARD M. MATHIAS, FRANCIS H. MORRISON, III; JASON MURATA, San Francisco, CA.
This disposition is nonprecedential.
Appeal from the United States District Court for the District of New Jersey in No. 2:20-cv-08966-SRC-CLW, Judge Stanley R. Chesler.
EDGAR HAUG, Haug Partners LLP, New York, NY, argued for plaintiffs-appellees. Also represented by KAITLIN FARRELL, PORTER F. FLEMING, SHEILA MORTAZAVI, ANDREW SCOTT ROPER.
CHAD A. LANDMON, Axinn, Veltrop &Harkrider LLP, Hartford, CT, argued for defendant-appellant. Also represented by THOMAS K. HEDEMANN, EDWARD M. MATHIAS,
FRANCIS H. MORRISON, III; JASON MURATA, San Francisco, CA.
JUDGMENT
THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM.
MOORE, Chief Judge, MAYER and HUGHES, Circuit Judges.
AFFIRMED. See Fed. Cir. R. 36.